Type 2 diabetic patients with non-alcoholic fatty liver disease exhibit significant haemorheological abnormalities

被引：7

作者：

Dong H. ^{[1
]}

Lu F. ^{[1
]}

Wang N. ^{[2
]}

Zou X. ^{[1
]}

Rao J. ^{[2
]}

机构：

[1] Institute of Integrative Traditional and Western Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology

[2] Department of Radiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology

来源：

Frontiers of Medicine | 2011年 / 5卷 / 3期

基金：

中国国家自然科学基金;

关键词：

diabetes mellitus; haemorheology; non-alcoholic fatty liver disease; type; 2;

D O I：

10.1007/s11684-011-0127-9

中图分类号：

学科分类号：

摘要：

Haemorheological abnormalities have been described in diabetes mellitus, as well as in non-alcoholic fatty liver disease (NAFLD). However, the relationship between the changes in liver fat content and haemorheology is unknown. The current study aims to show the correlation between haemorheological parameters and intrahepatic lipid content (IHLC) in patients with type 2 diabetes. The serum biochemical markers, such as fasting plasma glucose (FPG), haemoglobin A1c (HbA1c), liver enzymes, lipid profiles, and haemorheological properties, were examined. IHLC was quantified using proton magnetic resonance spectroscopy ( 1H-MRS) scanning of the liver. A significant correlation was observed between IHLC and whole blood viscosity at high, middle, and low shear rates. IHLC also positively correlated with haematocrit, the reduced whole blood viscosity at low and middle shear rates, and the erythrocyte aggregation index. Diabetic patients with NAFLD exhibited significant haemorheological abnormalities compared with patients without NAFLD. In summary, haemorheological disorders are linked to non-alcoholic fatty liver in type 2 diabetes. © 2011 Higher Education Press and Springer-Verlag Berlin Heidelberg.

引用

页码：288 / 293

页数：5

共 21 条

[1]

Angulo P., Lindor K.D., Non-alcoholic fatty liver disease, J Gastroenterol Hepatol, 17, SUPPL., (2002)

[2]

Targher G., Bertolini L., Padovani R., Rodella S., Tessari R., Zenari L., Day C., Arcaro G., Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients, Diabetes Care, 30, 5, pp. 1212-1218, (2007)

[3]

Le Devehat C., Vimeux M., Khodabandehlou T., Blood rheology in patients with diabetes mellitus, Clin Hemorheol Microcirc, 30, 3-4, pp. 297-300, (2004)

[4]

Ijaz S., Yang W., Winslet M.C., Seifalian A.M., Impairment of hepatic microcirculation in fatty liver, Microcirculation, 10, 6, pp. 447-456, (2003)

[5]

Sato N., Eguchi H., Inoue A., Matsumura T., Kawano S., Kamada T., Hepatic microcirculation in Zucker fatty rats, Adv Exp Med Biol, 200, pp. 477-483, (1986)

[6]

Yang W., Lu J., Weng J., Jia W., Ji L., Xiao J., Shan Z., Liu J., Tian H., Ji Q., Zhu D., Ge J., Lin L., Chen L., Guo X., Zhao Z., Li Q., Zhou Z., Shan G., He J., Prevalence of diabetes among men and women in China, N Engl J Med, 362, 12, pp. 1090-1101, (2010)

[7]

Seifalian A.M., Chidambaram V., Rolles K., Davidson B.R., In vivo demonstration of impaired microcirculation in steatotic human liver grafts, Liver Transpl Surg, 4, 1, pp. 71-77, (1998)

[8]

Wang N., Dong H., Wei S., Lu F., Application of proton magnetic resonance spectroscopy and computerized tomography in the diagnosis and treatment of nonalcoholic fatty liver disease, J Huazhong Univ Sci Technolog Med Sci, 28, 3, pp. 295-298, (2008)

[9]

Dagnelie P.C., Leij-Halfwerk S., Magnetic resonance spectroscopy to study hepatic metabolism in diffuse liver diseases, diabetes and cancer, World J Gastroenterol, 16, 13, pp. 1577-1586, (2010)

[10]

Szczepaniak L.S., Nurenberg P., Leonard D., Browning J.D., Reingold J.S., Grundy S., Hobbs H.H., Dobbins R.L., Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population, Am J Physiol Endocrinol Metab, 288, 2, (2005)

← 1 2 3 →